Convex, a leading Contract Research site in Eastern Europe specializing in Phase I clinical trials, including Single Ascending Dose (SAT) and Multiple Ascending Dose (MAT) first-in-man studies, is pleased to announce its participation at CPHI Europe 2025, taking place from October 28–30 at Messe Frankfurt, Germany.

By attending CPHI Europe, the Convex team aims to:
– Strengthen international partnerships with biotech and pharmaceutical companies.
– Present Convex’s capabilities in clinical research, healthy volunteer studies, and patient recruitment.
– Explore innovative solutions in drug development, medical devices, and clinical trial operations.

Convex’s presence at CPHI Europe underlines our commitment to excellence in clinical trials and our role as a trusted partner for global sponsors looking to conduct studies in Europe, Bulgaria.

We look forward to meeting potential partners in Frankfurt and discussing how Convex can support your next clinical development program.